APTOF · Aptose Biosciences Inc. · Debt
$1.69
+0.00 (+0.00%)
At close · Jul 3
Return incl. dividend (before tax)
Going-concern doubt
— flagged May 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The aforementioned conditions raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed May 13, 2026
Market Cap
$4.31M
Shares
2.55M
Volume · Jul 3
426
Avg daily vol (2 sessions)
531
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current operating lease liabilities | 2026-03-31 | USD 80,000 | 10-Q filed 2026-05-13 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.